Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
Maximizing Efficiency and Compliance with Expert Compendia and Monograph Review Services
Cactus Life Sciences specializes in compendia reviews, providing invaluable assistance to pharmaceutical companies. Our expert...
Digital Publication Extenders: Creating an Ecosystem for a More Engaging and Informative Experience
While creating digital publication extenders may seem complex, Cactus Life Sciences can assist in developing...
Uncovering the Benefits of Medical Review: A Comprehensive Overview
Medical review promises scientific data accuracy and has paramount importance at all the stages of...
Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21
A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...